Project Number EUJPND-Belgium-FIE-JANSSEN PHARMACEUTICA-284 Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Year 2016 View Full Project Details for AD Immunotherapy : Towards a disease modification therapy in Alzheimer disease via targeting Tau protein with monoclonal antibodies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator JANSSEN PHARMACEUTICA Principal Investigator First Name JANSSEN PHARMACEUTICA Principal Investigator Last Name JANSSEN PHARMACEUTICA Awardee Organization JANSSEN PHARMACEUTICA Contact PI Country Belgium Project Detail FY Overall Cost $142,472 Funding Organization Agency/Funding Organization Flanders Innovation & Entrepreneurship Funding Organization Country Belgium Special Initiative EU Joint Programme - Neurodegenerative Disease Research - Research Mapping (2016)
